What Medical Affairs Teams Need in a Video Review Platform for Promotional Content
Medical affairs video review platform requirements go beyond basic annotation. Claims traceability, version control, and a durable audit record are non-negotiable for promotional content.
Medical affairs teams reviewing promotional video content have requirements that most general-purpose video review tools simply do not address. When I talk to teams in this space, the complaints fall into predictable categories: no frame-level annotation, no way to link a comment to a specific claim, no audit trail that holds up in a compliance context, and a pricing model that charges per reviewer when your MLR committee has twelve people.
Let me walk through what a medical affairs team actually needs from a video review platform for promotional content, and how to evaluate tools against those real requirements.
The Baseline: Frame-Accurate Comments
This is the most fundamental requirement, and it is surprising how many tools still fail it. Promotional video content lives or dies at the claim level. "The voiceover at approximately 0:45" is not good enough when the regulatory significance of a single word at exactly 0:47 is the issue.
A medical reviewer needs to click a button at the exact frame where a claim appears and leave their annotation there. When the editor receives the note, they should be able to go directly to that frame without any ambiguity.
PlayPause gives frame-accurate, time-coded comments. Every annotation is pinned to the exact second (and frame within that second) where the reviewer clicked. For a regulatory reviewer flagging a claim that uses the word "significant" without statistical context, "at 0:47:22" is a precise instruction, not an approximation.
A comment about a specific promotional claim must be pinned to the exact moment the claim appears, not "around the middle" of the video.
Claims Traceability
Medical affairs teams need to be able to connect a video annotation to the underlying claim and its reference. This is a workflow requirement, not a technical one. The tool does not need to house the claims reference document; it needs to make it practical to cross-reference.
Here is how this works in practice with PlayPause. The content team uploads the video and a pinned annotation on the first frame that links to (or describes the location of) the claims reference document. Reviewers leave comments at specific frames noting the claim number they are challenging. The editor can see both the video comment and the claim number, pull up the reference document, and address the specific issue.
This is simpler than it sounds, but it requires a discipline: every promotional claim in the video must be numbered in the script, and the review comment should reference the claim number. "Claim 7: efficacy statement needs caveated language per PI section 6." That is an actionable note for both the editor and the medical writer.
Version Control That Keeps Reviews Honest
In a pharma promotional review, the version being reviewed matters a great deal. The Medical reviewer's comments on v1 apply to v1. If a Legal reviewer reviews v2 and v2 includes Medical-driven revisions, the Legal reviewer needs to know what changed.
Most tools fail this by treating versions as separate uploads with no relationship to each other. PlayPause stacks versions on a single project thread. V1 and all its comments are visible when you upload v2. The editor can see which v1 comments were addressed and which are still outstanding. A reviewer returning to check revisions can compare directly.
For an MLR process, this matters because partial re-reviews are common. If only one claim was revised, only the Medical reviewer who flagged it needs to re-review that specific change. Version stacking with visible comment history makes that targeted re-review practical.
| Feature | Why it matters for medical affairs |
|---|---|
| Frame-accurate comments | Claim-level annotation at the exact video moment |
| Version stacking | Partial re-review of specific changes without re-watching full video |
| Named guest reviewers | Each MLR committee member's notes are attributed |
| No-account review access | External reviewers (CRO, agency) need no seat or login |
| Link expiry and password protection | Sensitive pre-approval content stays controlled |
| Exportable comment trail | Audit record for regulatory archive |
| Flat workspace pricing | MLR committee of 12 does not cost 12 seats |
Frame-accurate note, everyone sees the exact same thing.
Audit Trail Requirements
For pharma promotional content, the review record is not just a project management convenience. It is a compliance artifact that demonstrates the content was reviewed by qualified medical, legal, and regulatory reviewers before promotion began.
The audit trail needs to show:
- Who reviewed each version
- When they reviewed it
- What comments they raised
- Whether those comments were addressed in a subsequent version
- Who gave final approval and when
- Frame-accurate annotations on specific claims
- All comments attributed to named reviewer
- Version history shows sequence of changes
- Comment thread exportable for regulatory archive
- Final approval logged as explicit comment from each MLR function
- Download controls on pre-approval versions
In PlayPause, the comment thread provides the first five automatically. Comments are attributed by name, time-stamped, and linked to a specific version. For the final approval documentation, medical affairs teams typically establish a convention: each MLR approver leaves an explicit "Medical Approved," "Legal Approved," "Regulatory Approved" comment on the final version. Those comments are time-stamped and attributed.
Exporting the comment thread from PlayPause gives you a complete review record that can be filed alongside the final video in a regulatory content management system.
Access Control for Pre-Approval Promotional Content
Pre-approval promotional content is sensitive by definition. A promotional video for an indication that has not yet received regulatory approval, or for a product where the promotional campaign has not been submitted to a regulatory body, is not for general distribution.
PlayPause review links can be password-protected and set to expire after a defined date. Downloads can be disabled so reviewers cannot retain local copies. For external reviewers (a contract medical communications agency, for example), guest access means they leave comments without gaining access to any other project in your workspace.
This is the practical access control model for medical affairs: tight scoping to the specific content being reviewed, time-limited, and with no persistent access that outlasts the review window.
For more on controlling access to sensitive video content during review, see our post on how to protect unreleased videos when sharing drafts for feedback.
No version control, comments in separate documents, no time-limited access control, audit trail reconstruction is painful
Version stacking, attributed frame-level comments, password-protected expiring links, exportable comment trail for compliance archive
Pricing Structure That Works for MLR Committee Size
Here is the practical problem with most enterprise video review tools: they charge per reviewer. An MLR committee with a medical director, two medical writers, two regulatory affairs reviewers, two legal counsel, and a promotional review coordinator is eight people. At a typical per-seat model, that is a significant per-project cost.
PlayPause charges flat per-workspace. Guest reviewers are free. Whether your MLR review involves three people or twelve, the workspace cost is the same. The reviewer count does not affect the bill.
For medical affairs teams at larger pharmaceutical companies, the Enterprise plan at $27 per month provides SSO, advanced access controls, and the organizational features that compliance teams expect. The Agency plan at $19 per month suits medical communications agencies managing promotional video review for multiple clients.
What to Look for in a Vendor Evaluation
If you are evaluating video review tools for medical affairs use, here are the questions I would ask in a vendor demo.
First, show me how a reviewer leaves a comment at a specific frame and how that comment appears in the review record. If the tool does not have frame-accurate annotation, it does not meet the baseline requirement.
Second, show me how versions are managed. Can I see v1 and v2 side by side with their respective comments? Can I see which v1 comments were addressed in v2?
Third, show me the audit trail. Can I export a time-stamped, reviewer-attributed comment log?
Fourth, what are the access controls on a review link? Can it expire? Can I disable downloads? Can I password-protect it?
Fifth, how are guest reviewers priced? If the answer is per seat, that is a red flag for a medical affairs use case.
For the step-by-step operational guide to running an MLR review, see our post on how to run an MLR review on a pharma marketing video step by step.
For more on regulatory reviewer annotation workflows, see our post on how pharma regulatory reviewers can annotate video claims without email chains.
The right video review platform for medical affairs is not the one with the most features. It is the one that produces a defensible audit record.
If your medical affairs team is currently managing promotional video review through email attachments and Word document comment logs, you are creating compliance risk that is easy to mitigate. Start PlayPause free and run your next promotional video review in a structured, traceable environment.
Priya Menon writes about video marketing and content workflows for PlayPause. She covers how marketing teams, brands, and creators review video, approve campaigns, and ship content faster.
Related resources
Keep reading
Bring your team into one review space
Centralize feedback, lock approvals, and deliver faster, start free today.
Sign Up for Free